Singulair

Chewable tablet, 4mg
RxActive license

Active substance (INN)

montelukast

Pharmaceutical form

Pharmaceutical formChewable tablet
Strength4mg
PackagingUkupno 28 tableta za žvakanje u blisteru (2x14) u kartonskoj kutiji
ManufacturerMerck Sharp & Dohme B.V., Netherlands
Therapeutic groupRespiratory system (R03DC03)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateJuly 20, 2023

Analogs in Montenegro

6

Other medicines with the same active substance

ALVOKASTRx
Film-coated tablet, 10mgPharmathen S.A.
ALVOKASTRx
Chewable tablet, 4mgPharmathen S.A.
ALVOKASTRx
Chewable tablet, 5mgPharmathen S.A.
SingulairRx
Chewable tablet, 5mgMerck Sharp & Dohme B.V.
SingulairRx
Film-coated tablet, 10mgMerck Sharp & Dohme B.V.
SingulairRx
Granules, 4mgMerck Sharp & Dohme B.V.
Source: CInMED register